Advanced company searchLink opens in new window

ELASTRIN THERAPEUTICS LIMITED

Company number 14203760

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
15 Jul 2024 CS01 Confirmation statement made on 28 June 2024 with updates
04 Jun 2024 AA Total exemption full accounts made up to 31 December 2023
26 Mar 2024 TM01 Termination of appointment of Alison Ruth Carter as a director on 26 March 2024
26 Mar 2024 TM01 Termination of appointment of David Alexander Brindley as a director on 26 March 2024
26 Jul 2023 AA Total exemption full accounts made up to 31 December 2022
11 Jul 2023 CS01 Confirmation statement made on 28 June 2023 with updates
05 Jul 2023 PSC05 Change of details for Elastrin Therapeutics Inc. as a person with significant control on 27 June 2023
04 Jul 2023 CH01 Director's details changed for Mr Matthias Breugelmans on 27 June 2023
04 Jul 2023 CH01 Director's details changed for Dr Alison Ruth Carter on 4 July 2023
04 Jul 2023 CH01 Director's details changed for Mr David Alexander Brindley on 27 June 2023
31 Oct 2022 AD01 Registered office address changed from 3 the Old Estate Yard High Street East Hendred Wantage Oxfordshire OX12 8JY England to 2 the Old Estate Yard High Street East Hendred Wantage Oxfordshire OX12 8JY on 31 October 2022
29 Jun 2022 AA01 Current accounting period shortened from 30 June 2023 to 31 December 2022
29 Jun 2022 NEWINC Incorporation
  • MODEL ARTICLES ‐ Model articles adopted

Statement of capital on 2022-06-29
  • GBP 100